 |
市場調查報告書
商品編碼
1638919
墨水匣市場機會、成長動力、產業趨勢分析和 2024 年至 2032 年預測Cartridges Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2024 to 2032 |
||||||
全球藥筒市場估值於2023 年達到18 億美元，預計2024 年至2032 年複合年成長率為7.6%。的。包括生物相容性玻璃和聚合物在內的先進材料的開發增強了藥物穩定性和相容性，使藥筒成為對製藥商和患者越來越有吸引力的選擇。
在準備方面，市場分為即用型（RTU）和即用型（RTS）部分。預計到 2032 年，RTU 領域將以 8% 的複合年成長率顯著成長，這得益於其為醫療保健提供者和患者帶來的便利和效率。 RTU 藥筒通常用於輸送生物製劑和胰島素，確保精確劑量，同時最大限度地降低污染風險。自我管理和家庭醫療保健解決方案的趨勢進一步支持了對 RTU 墨盒的需求，確保了其在市場上的領先地位。
按應用分類，全球卡盒市場分為小分子和生物製劑。生物製劑在 2023 年將佔據 70.1% 的市場佔有率，由於對精確、無污染的輸送系統的迫切需求，將推動對卡式盒的需求。專為單株抗體和重組蛋白等生物藥物設計的藥筒對於確保準確劑量以及維持藥物療效和安全性至關重要。對個人化醫療的日益關注和不斷成長的生物療法管道強調了基於藥筒的輸送系統的重要性，從而加強了它們在製藥領域的存在。
| 市場範圍 | |
|---|---|
| 開始年份 | 2023年 |
| 預測年份 | 2024-2032 |
| 起始值 | 18億美元 |
| 預測值 | 34億美元 |
| 複合年成長率 | 7.6% |
美國在北美墨盒市場佔據主導地位，預計在預測期內將保持這一領先地位，複合年成長率預計為 7.3%。美國市場受益於完善的製藥和生物技術產業，該產業優先發展創新的藥物輸送方法。強大的醫療保健基礎設施，加上自我管理設備的日益接受，有助於市場成長。監管支持和對以患者為中心的解決方案的重視也增強了美國在北美市場的地位。
整體而言，隨著對先進、使用者友善的給藥系統的需求成長，全球藥筒市場將穩步擴張。隨著材料和設計的不斷創新，藥筒日益成為慢性病管理和個人化醫療解決方案的重要工具，塑造了不同治療領域藥物傳遞的未來。
目錄
第 1 章：方法與範圍
第 2 章：執行摘要
第 3 章：產業洞察
- 產業生態系統分析
- 產業影響力
- 成長動力
- 慢性病發生率上升
- 越來越傾向於自我管理
- 藥物傳輸和製造技術不斷進步
- 生物製劑和生物相似藥研究活動的增加
- 產業陷阱與挑戰
- 製造成本高且複雜
- 嚴格的監管框架
- 成長動力
- 成長潛力分析
- 監管環境
- 未來市場趨勢
- 波特的分析
- PESTEL分析
第 4 章：競爭格局
- 介紹
- 公司矩陣分析
- 主要市場參與者的競爭分析
- 競爭定位矩陣
- 戰略儀表板
第 5 章：市場估計與預測：按準備情況，2021 - 2032 年
- 主要趨勢
- 即用型 (RTU)
- 準備滅菌 (RTS)
第 6 章：市場估計與預測：按應用分類，2021 - 2032
- 主要趨勢
- 小分子
- 生物製劑
第 7 章：市場估計與預測：按材料分類，2021 - 2032 年
- 主要趨勢
- 玻璃
- 聚合物
第 8 章：市場估計與預測：按規模，2021 - 2032
- 主要趨勢
- <1毫升
- 1毫升 - 2毫升
- 3毫升 - 5毫升
- 6 毫升 - 10 毫升
- 10 - 20 毫升
- 20 - 30 毫升
- >30 毫升
第 9 章：市場估計與預測：按最終用途，2021 - 2032 年
- 主要趨勢
- 醫院和診所
- 製藥和生物技術公司
- 合約開發與製造組織 (CDMO)
- 其他最終用戶
第 10 章：市場估計與預測：按地區，2021 - 2032
- 主要趨勢
- 北美洲
- 美國
- 加拿大
- 歐洲
- 德國
- 英國
- 法國
- 西班牙
- 義大利
- 亞太地區
- 中國
- 日本
- 印度
- 澳洲
- 韓國
- 拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 中東和非洲
- 南非
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
第 11 章：公司簡介
- AptarGroup
- Baxter
- Becton, Dickinson and Company (BD)
- Corning
- Daikyo Seiko
- Datwyler Holding
- Gerresheimer AG
- Merck KGaA
- Nipro
- Schott Group
- Shandong Medicinal Glass
- Stevanato Group
- Transcoject
- West Pharmaceutical Services
The Global Cartridges Market reached a valuation of USD 1.8 billion in 2023 and is anticipated to grow at a CAGR of 7.6% from 2024 to 2032. This growth is largely fueled by the rising demand for user-friendly, self-administered drug delivery systems, particularly for chronic conditions like diabetes and autoimmune diseases. The development of advanced materials, including biocompatible glass and polymers, enhances drug stability and compatibility, making cartridges an increasingly attractive option for pharmaceutical manufacturers and patients.
In terms of preparation, the market is divided into ready-to-use (RTU) and ready-to-sterilize (RTS) segments. The RTU segment is projected to experience significant growth at an 8% CAGR through 2032, driven by its convenience and efficiency for healthcare providers and patients. RTU cartridges are commonly used to deliver biologics and insulin, ensuring precise dosing while minimizing contamination risks. The trend toward self-administration and home healthcare solutions further supports the demand for RTU cartridges, securing their leading position in the market.
By application, the global cartridge market is categorized into small molecules and biologics. Biologics, which accounted for a substantial 70.1% of the market share in 2023, drive the demand for cartridges due to the critical need for precise, contamination-free delivery systems. Cartridges designed for biological drugs, such as monoclonal antibodies and recombinant proteins, are essential in ensuring accurate dosing and maintaining drug efficacy and safety. The expanding focus on personalized medicine and the growing pipeline of biologic therapies underscores the importance of cartridge-based delivery systems, strengthening their presence within the pharmaceutical sector.
| Market Scope | |
|---|---|
| Start Year | 2023 |
| Forecast Year | 2024-2032 |
| Start Value | $1.8 Billion |
| Forecast Value | $3.4 Billion |
| CAGR | 7.6% |
The United States holds a dominant position in the North American cartridges market and is expected to maintain this lead with a projected CAGR of 7.3% during the forecast period. The U.S. market benefits from a well-established pharmaceutical and biotech industry, which prioritizes the development of innovative drug delivery methods. A strong healthcare infrastructure, coupled with the increasing acceptance of self-administration devices, contributes to market growth. Regulatory support and an emphasis on patient-centric solutions also enhance the U.S.'s standing within the North American market.
Overall, the global cartridges market is set for steady expansion as demand for advanced, user-friendly drug delivery systems grows. With ongoing innovations in materials and design, cartridges are increasingly becoming essential tools in chronic disease management and personalized healthcare solutions, shaping the future of drug delivery across diverse therapeutic areas.
Table of Contents
Chapter 1 Methodology & Scope
- 1.1 Market scope & definition
- 1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
- 1.3 Base estimates & calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
- 1.4 Forecast model
- 1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources
Chapter 2 Executive Summary
- 2.1 Industry 360° synopsis
Chapter 3 Industry Insights
- 3.1 Industry ecosystem analysis
- 3.2 Industry impact forces
- 3.2.1 Growth drivers
- 3.2.1.1 Rising incidence of chronic disease
- 3.2.1.2 Growing preference for self-administration
- 3.2.1.3 Growing advances in pharmaceutical drug delivery and manufacturing technology
- 3.2.1.4 Rise in biologics and biosimilars research activities
- 3.2.2 Industry pitfalls & challenges
- 3.2.2.1 Hight cost and complexity in manufacturing
- 3.2.2.2 Stringent regulatory framework
- 3.2.1 Growth drivers
- 3.3 Growth potential analysis
- 3.4 Regulatory landscape
- 3.5 Future market trends
- 3.6 Porter's analysis
- 3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
- 4.1 Introduction
- 4.2 Company matrix analysis
- 4.3 Competitive analysis of major market players
- 4.4 Competitive positioning matrix
- 4.5 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Preparation, 2021 - 2032 ($ Mn and Units)
- 5.1 Key trends
- 5.2 Ready to Use (RTU)
- 5.3 Ready to Sterilize (RTS)
Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn and Units)
- 6.1 Key trends
- 6.2 Small molecules
- 6.3 Biologics
Chapter 7 Market Estimates and Forecast, By Material, 2021 - 2032 ($ Mn and Units)
- 7.1 Key trends
- 7.2 Glass
- 7.3 Polymer
Chapter 8 Market Estimates and Forecast, By Size, 2021 - 2032 ($ Mn and Units)
- 8.1 Key trends
- 8.2 <1 ml
- 8.3 1 ml - 2 ml
- 8.4 3 ml - 5 ml
- 8.5 6 ml - 10 ml
- 8.6 10 - 20 ml
- 8.7 20 - 30 ml
- 8.8 >30 ml
Chapter 9 Market Estimates and Forecast, By End Use, 2021 - 2032 ($ Mn and Units)
- 9.1 Key trends
- 9.2 Hospitals & clinics
- 9.3 Pharma & biotech companies
- 9.4 Contract Development and Manufacturing Organizations (CDMOs)
- 9.5 Other end user
Chapter 10 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn and Units)
- 10.1 Key trends
- 10.2 North America
- 10.2.1 U.S.
- 10.2.2 Canada
- 10.3 Europe
- 10.3.1 Germany
- 10.3.2 UK
- 10.3.3 France
- 10.3.4 Spain
- 10.3.5 Italy
- 10.4 Asia Pacific
- 10.4.1 China
- 10.4.2 Japan
- 10.4.3 India
- 10.4.4 Australia
- 10.4.5 South Korea
- 10.5 Latin America
- 10.5.1 Brazil
- 10.5.2 Mexico
- 10.5.3 Argentina
- 10.6 Middle East and Africa
- 10.6.1 South Africa
- 10.6.2 Saudi Arabia
- 10.6.3 UAE
Chapter 11 Company Profiles
- 11.1 AptarGroup
- 11.2 Baxter
- 11.3 Becton, Dickinson and Company (BD)
- 11.4 Corning
- 11.5 Daikyo Seiko
- 11.6 Datwyler Holding
- 11.7 Gerresheimer AG
- 11.8 Merck KGaA
- 11.9 Nipro
- 11.10 Schott Group
- 11.11 Shandong Medicinal Glass
- 11.12 Stevanato Group
- 11.13 Transcoject
- 11.14 West Pharmaceutical Services
